Capitala Finance Corp. Schedules Fourth Quarter and Full

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Capitala Finance Corp. Schedules Fourth Quarter and Full Year 2014 Earnings Release and Conference Call

CHARLOTTE, N.C., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Capitala Finance Corp. (Nasdaq: CPTA ) (the "Company" of "Capitala") announced today that it will report its fourth quarter and full year 2014 financial results on Wednesday, March 4, 2015 prior to the open of the financial markets.

Management will host a conference call to discuss the operating and financial results at 8:30 a.m. EST on Thursday, March 5, 2015. To participate in the conference call, please dial (877) 312-5507 approximately 10 minutes prior to the call. International callers should dial (253) 237-1134. Please reference conference ID #79626310.

A live webcast of the conference call will be available at http://investor.capitalagroup.com . Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software.

A telephone replay of the conference call will be available from 11:30 a.m. EST on March 5, 2015 until 11:59 p.m. EDT March 9, 2015, and may be accessed by dialing (855) 859-2056 and reference conference ID #79626310. An archived replay of the conference call will also be available in the investor relations section of the Company's website. 

About Capitala Finance Corp.

Capitala Finance Corp. is a business development company that invests primarily in traditional mezzanine, senior subordinated and unitranche debt, as well as senior and second-lien loans and, to lesser extent, equity securities issued by lower and traditional middle-market companies. The Company is managed by Capitala Investment Advisors, LLC. For more information about the Company, please visit www.CapitalaGroup.com .

Forward-Looking Statements

This press release contains certain forward-looking statements. Words such as "believes," "intends," "expects," "projects," "anticipates," and "future" or similar expressions are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

Capitala Finance Corp. Stephen Arnall, Chief Financial Officer 704-376-5502

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Waystar Sees Stellar Q1 2025 Results With Revenue Increase

Updated Category News Views 624

Waystar Reports Stellar Q1 2025 Financial Results In the latest announcement, Waystar Holding Corp. (NASDAQ: WAY) has highlighted significant achievements for the first quarter of 2025, showcasing robust financial progress and promising future guidance. The company achieved an impressive revenue growth rate of 14% year-over-year, reflecting its continuing success as a...

Continue Reading
Innovative Power MOSFET to Boost Efficiency in AI Server Tech

Updated Category News Views 180

Revolutionizing AI Server Power Solutions ROHM Semiconductor has taken a significant step in advancing the technology landscape with their latest power MOSFET, the RS7P200BM. This innovative component is crafted specifically for AI servers, functioning within a compact 5.0mm × 6.0mm package. The introduction of this 100V power MOSFET stems from the increasing demands for...

Continue Reading
Sarclisa Gains EU Approval for New Multiple Myeloma Treatment

Updated Category News Views 319

Sarclisa Approved in the EU for New Treatment of Multiple Myeloma Sarclisa has recently achieved a significant milestone by obtaining approval in the European Union as the first anti-CD38 therapy designed for use in combination with the standard-of-care regimen known as VRd, to treat adult patients with newly diagnosed multiple myeloma (NDMM) who are not eligible for...

Continue Reading
Lifecore Biomedical Investors: Navigate Legal Rights with Precision

Updated Category News Views 83

Your Rights as a Lifecore Investor If you’ve invested in Lifecore Biomedical, Inc., you're at a key juncture as you navigate the complexities of legal action stemming from potential corporate misconduct. Understanding your options is crucial during this time. Details on the Class Action The Portnoy Law Firm has officially announced a class action for Lifecore...

Continue Reading
Natural Grocers Crowned Top Organic Retailer in 2024 Contest

Updated Category News Views 237

Natural Grocers Leads the Way in Organic Retail Natural Grocers is proud to announce that it has been named "Best Natural Food Stores for 2024" in a contest hosted by Green Matters. This award is a significant achievement, highlighting the company’s dedication to offering premium natural and organic products. A Well-Deserved Honor This recognition resulted from a public...

Continue Reading